Hong Kong stocks' innovative drug sector fell in early trading, with BeiGene falling more than 3%
2024-12-05 09:46:53
The Hong Kong stock market's innovative drug sector fell in early trading, with BeiGene falling more than 3%, WuXi Biologics falling more than 2%, China Biologic Products, Innovent Biologics, Shanghai Pharmaceuticals and others falling.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up
to date with North American business news.
Weekly Highlights